Novavax
Latest
EU delays approval of Novavax’s revised COVID vaccine – FT
Oct 15 (Reuters) - European Union (EU) regulators have delayed a decision to give approval for Novavax's variant-tailored COVID-19 vaccine, the Financial Times said on Sunday. The European Medicines Agency…
Novavax says COVID-19 shot 80% effective in adolescent study
Novavax Inc said its two-dose vaccine was 80% effective against COVID-19 in a late-stage trial testing the shot in teens aged 12…
EU regulator backs Novavax shot as region’s fifth COVID-19 vaccine
Dec 20 (Reuters) - The European Union's drug regulator on Monday approved use of the COVID-19 vaccine from U.S.-based Novavax in people…
Novavax COVID-19 vaccine shows 90.4% efficacy in late stage trial
Novavax Inc said on Monday its COVID-19 vaccine candidate showed 90.4% overall efficacy against the disease in a late-stage trial. The American…
Novavax vaccine shows 51% efficacy against South African variant, study finds
Novavax Inc's COVID-19 vaccine had efficacy of 51% against infections caused by the South African variant among people who were HIV negative,…
EU Commission sees potential in protein-based COVID-19 vaccines
Th EU Commission may eventually expand its portfolio of COVID-19 jabs to protein-based vaccines, the EU executive's President Ursula von der Leyen…
GSK to fill up to 60 million Novavax vaccine doses for Britain
GlaxoSmithKline has agreed in principle to handle the final part of the manufacturing process or up to 60 million doses of Novavax's…
Novavax vaccine 96% effective against original coronavirus, 86% vs British variant in UK trial
Novavax Inc’s COVID-19 vaccine was 96% effective in preventing cases caused by the original version of the coronavirus in a late-stage trial…
EXCLUSIVE – EU seeks more Moderna COVID-19 vaccines, eyes deals with Valneva, Novavax
BRUSSELS/MILAN, Jan 11 (Reuters) - The European Union is in talks with Moderna to order more of its COVID-19 vaccine despite the…
Novavax initiates late-stage COVID-19 vaccine trial in UK
Novavax Inc on Thursday started a late-stage trial of its experimental COVID-19 vaccine in the United Kingdom in partnership with the government's…